Hantavirus cases spark surge in pharma, biotech stocks — here’s why
ILLUSTRATION of hantavirus testing concept with laboratory tubes containing cotton swabs and HANTAVIRUS labels photographed in front of…
FDA withdrew studies finding Covid, shingles vaccines were safe
The FDA blocked the publication of several studies supporting the safety of vaccines against Covid and shingles in…
An appreciation: J. Craig Venter, pioneer of modern genomics
J. Craig Venter, a scientist whose relentless ambition helped turn genetics from an artisanal trade into an industrialized…
Intellia Therapeutics moves HAE treatment closer to approval
Intellia Therapeutics said Monday that a single dose of its gene editing treatment dramatically reduced swelling attacks in…
Erasca touts strong early results in pancreatic and lung cancer therapy trial
Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall…
Regeneron inks drug pricing deal with Trump, will offer hearing-loss therapy for free
U.S. President Donald Trump (C) speaks during an event on advancing health care affordability in the Oval Office…
Eli Lilly’s $3.25B acquisition of Kelonia Therapeutics caps startup’s tortuous ride
Eli Lilly is spending $3.25 billion to acquire Kelonia Therapeutics, a small biotech company developing cell therapies for…
Lilly to acquire Kelonia Therapeutics to advance in vivo CAR-T cell therapies
Kelonia’s lead program, KLN-1010, is a potentially first-in-class lentiviral in vivo CAR-T therapy currently in Phase 1 for…
Trump nominates Erica Schwartz as CDC director
A sign sits outside of the Centers for Disease Control and Prevention (CDC) Roybal campus in Atlanta, Georgia,…
Revolution Medicines touts success in pancreatic cancer treatment
Metastatic pancreatic cancer patients who received a targeted pill from Revolution Medicines lived nearly twice as long as…
Replimune skin cancer drug that became FDA flashpoint is rejected again
The Food and Drug Administration on Friday rejected — again — an experimental treatment for advanced skin cancer…
Trump prepares pharmaceutical tariffs of up to 100%
The Trump administration is preparing to impose new tariffs on branded drugs from pharmaceutical companies that have not…